¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"paramagnetic proton relaxation enhancement"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proton relaxation
    ¾ç¼ºÀÚÀÌ¿Ï
  • nuclear paramagnetic resonance
    ÇÙ»óÀÚ¼º°ø¸í
  • paramagnetic ion
    »óÀÚ¼ºÀÌ¿Â
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • acoustic enhancement
    ¼Ò¸®Áõ°­, À½ÇâÁõ°­
  • contrast enhancement
    Á¶¿µÁõ°­
  • contrast enhancement ratio
    Á¶¿µÁõ°­ºñ
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • edge enhancement
    °¡ÀåÀÚ¸®Áõ°­
  • enhancement
    1. ÃËÁø 2. Áõ°­ 3. °­È­
  • enhancement medium
    Áõ°­¹èÁö
  • oxygen enhancement ratio
    »ê¼ÒÈ¿°úÁõ°­·ü, »ê¼ÒÁõ°­ºñ
  • rim enhancement
    Å×Áõ°­
  • ring enhancement
    °í¸®Á¶¿µÁõ°­
  • deshielded proton
    ¹ÌÂ÷Æó¾ç¼ºÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enhancement
    Áõ°­, ÁõÁø
  • proton density
    ¾çÀڹеµ
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • proton
    ¾ç¼ºÀÚ
  • relaxation exercise
    À̿Ͽ¬½À
  • relaxation phase
    À̿ϱâ, À̿ϻó
  • relaxation
    ÀÌ¿Ï, Ç®¸²
  • relaxation rate
    À̿Ϸü
  • relaxation state
    À̿ϻóÅÂ
  • relaxation training
    ÀÌ¿ÏÈÆ·Ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility proton relaxation enhancement
    ÀÚ±âÈ­À²¾ç¼ºÀÚÀÌ¿ÏÁõ°­
  • proton relaxation
    ¾çÀÚÇ®¸², ¾çÀÚÀÌ¿Ï
  • paramagnetic ion
    »óÀÚ¼ºÀÌ¿Â
  • nuclear paramagnetic resonance
    ÇÙ»óÀÚ¼º°ø¸í
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • deshielded proton
    ¹ÌÂ÷Æó¾ç¼ºÀÚ
  • proton density
    ¾çÀڹеµ
  • proton flow deficit
    ¾çÀÚÈ帧°áÇÌ
  • free water proton
    ÀÚÀ¯¹°¾ç¼ºÀÚ
  • high intensity proton flow
    °í°­µµ¾çÀÚÈ帧, °í°­µµ¾çÀÚÀ¯µ¿
  • proton flow
    ¾çÀÚÈ帧, ¾çÀÚÀ¯µ¿
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • nonsaturated proton
    ºñÆ÷È­¾çÀÚ
  • proton
    ¾ç¼ºÀÚ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
  • High intensity proton flow
    °í°­µµ ¾çÀÚ À¯µ¿
  • free water proton
    ÀÚÀ¯ ¼öºÐ ¾ç¼ºÀÚ
  • proton
    ¾ç¼ºÀÚ(åÕàõí­).
  • proton
    ¾ç¼ºÀÚ
  • proton (spin) density
    ¾çÀÚ ¹Ðµµ
  • proton beam therapy
    ¾çÀÚ¼±Ä¡·á
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighted image
    ¾çÀÚ ¹Ðµµ °­Á¶ ¿µ»ó
  • recoil proton
    ¹Ýµµ¾çÀÚ
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • acoustic enhancement
    À½Çâ Áõ°­
  • immune enhancement
    ¸é¿ªÇÐÀûÃËÁø (Á¾¾çÁõ½ÄÀÇ)
  • immunological enhancement
    ¸é¿ªÁõ°­.
  • immunological enhancement
    ¸é¿ªÁõ°­.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proton relaxation enhancement
    ¾çÀÚ ÀÌ¿Ï Áõ°­
  • proton proton dipole dipole interaction
    ¾çÀÚ ¾çÀÚ ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£¹ÝÀÀ
  • proton relaxation
    ¾çÀÚ ÀÌ¿Ï
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
  • nuclear paramagnetic resonance
    ÇÙ »óÀÚ¼º °ø¸í
  • paramagnetic
    »óÀÚ¼ºÀÇ, »óÀÚ¼ºÃ¼ÀÇ
  • paramagnetic agent
    »óÀÚ¼º Á¦Àç
  • paramagnetic component
    »óÀÚ¼º ¼ººÐ
  • paramagnetic high susceptibility
    »óÀÚ¼º °íÀÚÈ­À²
  • paramagnetic ion
    »óÀÚ¼º ÀÌ¿Â
  • paramagnetic substance
    »óÀÚ¼º ¹°Áú
  • paramagnetic susceptibility effect
    »óÀÚ¼º ÀÚ±âÈ­ È¿°ú
  • deshielded proton
    ¹ÌÂ÷Æó ¾ç¼ºÀÚ
  • free water proton
    ÀÚÀ¯ ¼öºÐ ¾ç¼ºÀÚ
  • low intensity void in proton flow
    ¾ç¼ºÀÚ È帧ÀÇ Àú°­µµ ¼Ò½Ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • electron paramagnetic resonance
    ÀüÀÚ»óÀÚ¼º °ø¸í(ï³í­ßÈí¸àõÍìÙ°)
  • paramagnetic
    »óÀڱ⼺(ßÈí¸Ñ¨àõ)
  • enhancement
    Áõ°­(ñòË­)
  • enhancement effect
    Áõ°­ È¿°ú (ñòË­üùÍý)
  • fluorescence enhancement
    Çü±¤ Áõ°­(û«ÎÃñòË­)
  • immunological enhancement
    ¸é¿ª Áõ°­(Øóæ¹ñòË­)
  • migration enhancement factor
    À̵¿Ç×Áø ÀÎÀÚ(ì¹ÔÑùñòäì×í­)
  • longitudinal relaxation
    Á¾ÀÌ¿Ï(ðôì¬èÐ)
  • relaxation
    ÀÌ¿Ï(ì¬èÐ)
  • relaxation complex
    ÀÌ¿Ï º¹ÇÕü(ì¬èÐÜÜùêô÷)
  • relaxation effect
    ÀÌ¿Ï È¿°ú(ì¬èÐüùÍý)
  • relaxation kinetics
    ÀÌ¿Ï ¿ªµ¿ÇÐ(ì¬èÐæ³ÔÑùÊ)
  • relaxation protein
    ÀÌ¿Ï ´Ü¹éÁú(ì¬èÐÓ±ÛÜòõ)
  • relaxation technique
    ÀÌ¿Ï ¼ú(ì¬èÐâú)
  • relaxation time
    ÀÌ¿Ï ½Ã°£(ì¬èÐãÁÊà)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º¾çÀÚÀÌ¿ÏÁõ°­
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • proton relaxation enhancement
    ¾çÀÚÀÌ¿ÏÁõ°­
  • proton proton dipole dipole interaction
    ¾çÀÚ¾çÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • rapid acquisition with relaxation enhancement [=RARE]
    ÀÌ¿ÏÁõ°­±Þ¼Óȹµæ
  • proton relaxation
    ¾çÀÚÀÌ¿Ï
  • nuclear paramagnetic resonance
    ÇÙ»óÀÚ¼º°ø¸í
  • paramagnetic
    »óÀÚ¼ºÀÇ, »óÀÚ¼ºÃ¼ÀÇ
  • paramagnetic agent
    »óÀÚ¼ºÁ¦Àç
  • paramagnetic component
    »óÀÚ¼º¼ººÐ
  • paramagnetic high susceptibility
    »óÀÚ¼º°íÀÚÈ­À²
  • paramagnetic ion
    »óÀÚ¼ºÀÌ¿Â
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • paramagnetic susceptibility effect
    »óÀÚ¼ºÀÚ±âÈ­È¿°ú
  • acoustic enhancement
    À½ÇâÁõ°­
  • CE [=contrast enhancement]
    Á¶¿µÁõ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PRE photoreacting enzyme; physician's report of examination; pigmented retinal epithelium; preplacement ...
PMR patient meta-record; perinatal mortality rate; periodic medical review; physical medicine and rehabi...
PRR proton relaxation rate; pulse repetition rate
RARE rapid acquisition with relaxation enhancement
EPR early progressive resistance; electron paramagnetic resonance; electronic patient record; electrophr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PRR proton relaxation rate
RARE Rapid Acquisition with Relaxation Enhancement
EPR Electron Paramagnetic Resonance
EPR Electron Paramagnetic Resonance Spectroscopy
EPRI Electron paramagnetic resonance imaging
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • proton proton dipole dipole interaction
    ¾çÀÚ ¾çÀÚ ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ ¹ÝÀÀ
  • proton relaxation
    ¾çÀÚ ÀÌ¿Ï
  • paramagnetic agent
    »óÀÚ¼º Á¦Àç
  • paramagnetic high susceptibility
    »óÀÚ¼º °íÀÚÈ­À²
  • paramagnetic susceptibility effect
    »óÀÚ¼º ÀÚ±âÈ­ È¿°ú
  • high intensity proton flow
    °í°­µµ ¾çÀÚÀ¯µ¿
  • nonsaturated proton
    ºñÆ÷È­ ¾çÀÚ
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighting
    ¾çÀÚ °­Á¶
  • proton flow
    ¾çÀÚ À¯µ¿
  • proton flow deficit
    ¾çÀÚ À¯µ¿ °áÇÌ
  • proton spin density
    ¾çÀÚ ¹Ðµµ
  • acoustic enhancement
    À½Çâ Áõ°­
  • contrast enhancement
    Á¶¿µ Áõ°­
  • contrast enhancement scan
    Á¶¿µ Áõ°­ ½ºÄµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
paramagnetic Magnetic, as opposed to diamagnetic.
A paramagnetic substance. Paramagnet"ically.
Origin: Pref. Para- + magnetic.
Source: Websters Dictionary
(01 Mar 1998)
electron paramagnetic resonance <physics> A spectrometric method, based on measurement of electron spins and magnetic moments, for detecting and estimating free radicals in reactions and in biological systems.
Synonym: electron paramagnetic resonance.
(05 Mar 2000)
membrane-bound proton-translocating PPi synthase <enzyme> From rhodospirillum rubrum; functions as an alternative coupling factor; n,n'-dicyclohexylcarbodiimide-sensitive; catalyses the phosphorylation of pi to ppi, the hydrolysis of ppi and the concomitant translocation of proton across the plasma membrane
Registry number: EC 3.6.1.-
Synonym: h(+)-ppi synthase
(26 Jun 1999)
proton <physics> An elementary atomic particle with a positive charge and a mass of about 1 amu.
(09 Oct 1997)
proton acceptor <chemistry> A base, an anionic substance that acceptsa proton during an acid-basereaction.
(09 Oct 1997)
proton ATPase <enzyme> An ion pump that actively transports hydrogen ions across lipid bilayers in exchange for ATP.
Major groups are the F-type ATPases, that run in reverse to synthesise ATP in bacterial, mitochondrial and chloroplast membranes (ATP synthase) and the V-type ATPases found in intracellular vesicles with an acidic lumen and on certain epithelial cells (e.g. Kidney intercalated cells). Gastric H/K ATPase is a proton ATPase.
(18 Nov 1997)
proton donor <chemistry> An acid, a susbstance that donates protons in an acid-base reduction reaction.
(10 Jan 1998)
proton-motive force Energy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work. Proton-motive force can be generated by a variety of phenomena including the operation of an electron transport chain, illumination of a purple membrane, and the hydrolysis of ATP by a proton atpase.
(12 Dec 1998)
proton pump Integral membrane proteins that transport protons across a membrane against a concentration gradient. This transport is driven by hydrolysis of ATP by hydrogen-transporting ATP synthase.
(12 Dec 1998)
proton pump inhibitor <pharmacology> A group of anti-ulcer medications which work by binding to H+/K+ ATPase, an enzyme which is found on the secretory surface of parietal cells. It thereby inhibits the final transport of hydrogen ions (via exchange with potasium) into the gastric lumen.
Examples of proton pump inhibitors include omeprazole and lansoprazole.
(27 Sep 1997)
acoustic enhancement A manifestation of increased acoustic signal amplitude returning from regions beyond an object which causes little or no attenuation of the sound beam.
Compare: acoustic shadow.
(05 Mar 2000)
antibody-dependent enhancement Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by fc receptors (receptors, fc) or by complement receptors (receptors, complement). Either the virus is complexed with antiviral IgG and binds to fc receptors, or virus is coated with antiviral IgM and binds to complement receptors.
(12 Dec 1998)
radiographic image enhancement Improvement in the quality of an X-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed.
(12 Dec 1998)
graft enhancement, immunologic The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
(12 Dec 1998)
ring enhancement In computed tomography, when a bright circle appears on an image made after injection of contrast medium, characteristic of localization of the contrast in the wall of an abscess.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • paramagnetic
    »óÀÚ¼ºÀÇ;»óÀÚ¼º
  • relaxation
    ´ÊÃß±â
  • enhancement
    (°¡°Ý,¸Å·Â,°¡Ä¡ µîÀÇ)»ó½Â;µî±Í;Çâ»ó;Áõ´ë
  • relaxation
    (±äÀå.±ÙÀ°.Á¤½ÅµîÀÇ)Ç®¸².ÀÌ¿Ï;°æ°¨;¿ÏÈ­;¼è¾à;Á¤·Â°¨Åð;ÈÞ¾ç;ÆíÈ÷ ½°;±âºÐ Àüȯ(Ç®ÀÌ);±âºÐ ÀüȯÀ¸·Î ÇÏ´ÂÀÏ;¿À¶ô;·¹Å©¸®¿¡À̼Ç
  • revenue enhancement
    ¼¼ÀÔ Áõ°¡(Áõ¼¼¶ó´Â ¸» ´ë½Å ¾²´Â Ç¥Çö)
  • proton
    ¾çÀÚ
  • proton
    ÇÁ·ÎÅæ;¾çÀÚ. protonic a.
  • proton decay
    ¾çÀÚ ºØ±«
  • proton synchrotron
    ¾çÀÚ °¡¼Ó ÀåÄ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á